Compare CRNX & WPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRNX | WPP |
|---|---|---|
| Founded | 2008 | 1985 |
| Country | United States | United Kingdom |
| Employees | N/A | 104000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.0B |
| IPO Year | 2018 | N/A |
| Metric | CRNX | WPP |
|---|---|---|
| Price | $33.65 | $15.35 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 2 |
| Target Price | ★ $74.78 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 665.2K |
| Earning Date | 05-07-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 13.67% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,039,000.00 | N/A |
| Revenue This Year | $722.66 | N/A |
| Revenue Next Year | $183.79 | $2.48 |
| P/E Ratio | ★ N/A | $38.96 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $24.10 | $14.81 |
| 52 Week High | $57.99 | $40.95 |
| Indicator | CRNX | WPP |
|---|---|---|
| Relative Strength Index (RSI) | 29.20 | 34.70 |
| Support Level | $33.23 | $14.81 |
| Resistance Level | $37.23 | $19.55 |
| Average True Range (ATR) | 1.62 | 0.51 |
| MACD | 0.13 | 0.05 |
| Stochastic Oscillator | 8.33 | 19.85 |
Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.
Headquartered in the United Kingdom, WPP is the world's largest ad holding company based on annual revenue. Its services, which include traditional and digital advertising, public relations, and consulting, are provided worldwide, with over 70% of its revenue coming from more developed regions such as North America, the UK, and Western Europe. WPP is the largest media buying entity in the world.